Skip to main content

Table 1 Patient characteristics and outcomes

From: Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008

Characteristics

All patients (n = 90) 5% of all breast cancers (n = 1800)

Patients with nonmetastatic disease (n = 72)

Patient’s characteristics

  

Age

  

  Median

47

47

  Range

29 - 75

29 - 75

Menoposal status

  

  Premenoposal

51 (56.7%)

38 (53%)

  Postmenoposal

34 (37.8%)

30

  Unknown

5

4

Histilogy

  

  Infiltrating ductal carcinoma

84 (93.3%)

69 (96%)

  Infiltrating lobular carcinoma

3 (3.3%)

2

  Other

3 (3.3%)

3

SBR

  

  I

5 (5.6%)

4

  II

45 (50%)

36

  III

24 (26.7%)

20

  Unknown

16 (17.7%)

12

Hormone receptor status

  

  ER+/PR+

37

30

  ER+/PR-

0

0

  ER-/PR+

23

19 (26.4%)

  ER-/PR-

4

4 (5.6%)

  Unknown

26

19

HER2/neu status

  

  Positif

23 (25.5%)

18 (25%)

  Negatif

22

20

  Unknown

45

34

Clinical stage N

  

  N0

31 (34.4%)

23 (32%)

  N1

42 (46.7%)

33

  N2

12 (13.3%)

12

  N3

5 (5.6%)

4

Clinical stage M

  

  M0

72 (80%)

72

  M1

18 (20%)

0

Taxanes

  

  Yes

45

37 (51.4%)

  No

43

35 (48.6%)

  Unknown

2

0

Surgery

  

  Yes

53

51 (71%)

  No

37

21 (29%)

Radiotherapy

  

  Yes

40

39 (54%)

  No

50

33 (36%)

  cOR (CR + PR)

-

49 (68%)

  pCR

-

1 (1.4%)

  Pathologically negative lymph nodes

 

5 (7%)

  1 and 2 y LRRFS

-

90.8%; 78.1%

  1 and 2 y EFS

-

81.7%; 57.5%

  1 and 2 y OS

-

94.3%; 74.6%